Active, Not Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Hospital Italiano de Buenos Aires ABB, Argentina
- Clinica Privada Banfield Banfield, Argentina
- Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM) Buenos Aires, Argentina
- Stat Research S.A. Buenos Aires, Argentina